Automated and enhanced clone screening using a fully automated microtiter plate-based system for suspension cell culture by Markert, Sven et al.
 Thursday, May 10, 2018                                                                                                                         Session 9 
AUTOMATED AND ENHANCED CLONE SCREENING USING A FULLY AUTOMATED MICROTITER 
PLATE-BASED SYSTEM FOR SUSPENSION CELL CULTURE 
 
Sven Markert, Roche Diagnostics GmbH, Pharmaceutical Biotech Production and Development, Penzberg 
sven.markert@roche.com 
Carsten Musmann, Roche Diagnostics GmbH, Pharmaceutical Biotech Production and Development, Penzberg 
Klaus Joeris, Roche Diagnostics GmbH, Pharmaceutical Biotech Production and Development, Penzberg 
Peter Hülsmann, Roche Diagnostics GmbH, pRED, Large Molecule Research, Penzberg 
 
 
Key Words: early stage clone characterization; glycosylation analysis; RT-qPCR analysis; automated clone 
screening; clone evaluation parameters 
 
In this talk we will present how we accelerated a clone selection process by 4 weeks while increasing the 
information density obtained for each clone. This was achieved by increasing the throughput and integrating 
new powerful analytical technologies as gene expressions and glycosylation analysis at a very early stage. 
Additionally, we could identify the overall top clone that was lost during the pre-selection phase of the reference 
process which is based on a considerably lower automation degree.  
 
Using our in-house developed MTP-based cell culture system for clone screening and selection offers 
substantial potential for improvement and acceleration: The system provides a fully automated process and 
enables fed-batch cultivation at an early stage which is of high importance for successful clone selection. Due 
the high throughput of more than 600 cultivations at the same time the MTP-based system considerably 
increases the number of clones that can be evaluated and speeds up the processing. The potential to integrate 
real-time monitoring of metabolites and other secondary selection criteria crucial for productivity and product 
quality further supports reliable clone selection. Moreover, the MTP-based system establishes an interface for 
advanced HT analytics to identify additional parameters for clone evaluation. Thus, we demonstrated the 
technical feasibility to couple the MTP-based cell culture system with glycosylation analysis as well as the 
LightCycler® technology to perform automated RT-qPCR gene expression analysis for a large number of cell 
culture samples. The results of the RT-qPCR analysis showed that the identified top clone displayed the highest 
mRNA expression level for the HC of the examined mAb which correlated with the highest specific productivity 
recorded at the protein level. Furthermore, RT-qPCR analysis may also be beneficial to monitor the expression 
of stress markers like chaperones and factors related to endoplasmic reticulum stress potentially correlating with 
product concentration or it can be applied to improve prediction of clone stability attributes related to promoter 
methylation or transgene copy number. 
 
This particular advancement combined with the high flexibility of the system opens up future perspectives for 
optimizing the selection process at an early stage, e.g. by using multiple selection criteria that are especially 
tailored for each product. The early availability of product quality data will also improve the chances to select the 
most suitable clone and to reduce risks and required effort during later development stages. This is of particular 
importance when expressing complex molecule formats such as bispecific antibodies, glycoengineered 
antibodies or antibody cytokine fusion proteins. Our high-throughput MTP-based cell culture system appears 
most suitable to enhance efficiency and robustness of the clone screening procedure as well as the quality of 
the selected clones. Product quality control can be reached by selecting the clone with the desired product 
quality pattern at a very early stage using our cell culture system that is proven to be predictive for large scale 
bioreactors. 
 
